As AI techniques continue to improve and more data becomes available, it will be important for researchers, clinicians, and regulators to collaborate in addressing these challenges. This collaboration is essential for harnessing the full potential of AI in clinical trial outcome prediction, enabling us to better manage complex diseases and provide personalized medical treatment to patients.